Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 2,812 | 3,260 | 3,821 | 4,374 |
| Receivables | 74 | 55 | 41 | 17 |
| TOTAL | $3,071 | $3,675 | $4,103 | $4,805 |
| Non-Current Assets | ||||
| Intangibles | 5,587 | 5,722 | 5,858 | 5,991 |
| TOTAL | $5,587 | $5,722 | $5,858 | $5,991 |
| Total Assets | $8,658 | $9,397 | $9,960 | $10,796 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 40 | 106 | 73 | 267 |
| TOTAL | $114 | $189 | $156 | $323 |
| Non-Current Liabilities | ||||
| TOTAL | $0 | $0 | $0 | $0 |
| Total Liabilities | $114 | $189 | $156 | $323 |
| Shareholders' Equity | ||||
| Common Shares | 13,575 | 13,575 | 13,575 | 13,522 |
| Retained earnings | -5,521 | -4,770 | -4,032 | -3,197 |
| TOTAL | $8,544 | $9,208 | $9,804 | $10,473 |
| Total Liabilities And Equity | $8,658 | $9,397 | $9,960 | $10,796 |